No Data
No Data
Johnson & Johnson (JNJ.US) is negotiating to acquire the $10 billion market cap biotech star Intra-Cellular, and the medical merger wave is surging again!
Johnson & Johnson is in talks to acquire the biopharmaceutical company Intra-Cellular Therapies Inc., which focuses on treating central nervous system diseases, and both parties may reach an agreement as early as this week.
Plug Power, Capri And Frontline Are Among Top Mid Cap Gainers Last Week (Jan 6-10): Are The Others In Your Portfolio?
Key Deals This Week: FuboTV - Disney, Constellation Energy, Eli Lilly, Phillips 66, Intercontinental Exchange and More
Weekly Buzz: CES Came and Brought the Pain? That's Unexpected
Wall Street Today: Labor Gains Hurt a Hurting Market
First Earnings Show Beats are Back, December Jobs Climbed but Market Falls Friday | Live Stock
Buy n Die Together❤ :
watuzzi : lets goo
72368432 :
TRIUMPHANT RETURNS :
Ryu983 :
View more comments...